These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Risk factors for diabetic complications: Abnormality of polyol metabolism]. Hotta N Nihon Rinsho; 2002 Oct; 60 Suppl 10():60-6. PubMed ID: 12430208 [No Abstract] [Full Text] [Related]
3. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330 [TBL] [Abstract][Full Text] [Related]
4. Has one diabetic complication been explained? Winegrad AI; Simmons DA; Martin DB N Engl J Med; 1983 Jan; 308(3):152-4. PubMed ID: 6848907 [No Abstract] [Full Text] [Related]
5. [Nicotinamide coenzyme regulation of the sorbitol pathway of glucose metabolism in the aorta of rats with streptozotocin diabetes]. Obrosova IG; Velikiĭ NN; Efimov AS Vopr Med Khim; 1985; 31(2):125-8. PubMed ID: 3159151 [TBL] [Abstract][Full Text] [Related]
6. Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway. Travis SF; Morrison AD; Clements RS; Winegrad AI; Oski FA J Clin Invest; 1971 Oct; 50(10):2104-12. PubMed ID: 4398937 [TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Gabbay KH Annu Rev Med; 1975; 26():521-36. PubMed ID: 238458 [TBL] [Abstract][Full Text] [Related]
8. [New theories of the pathogenesis of diabetic neuropathies]. Lekishvili VP Klin Med (Mosk); 1974 Nov; 52(11):14-6. PubMed ID: 4373612 [No Abstract] [Full Text] [Related]
9. Direct measurement of polyol pathway activity in the ocular lens. González RG; Barnett P; Aguayo J; Cheng HM; Chylack LT Diabetes; 1984 Feb; 33(2):196-9. PubMed ID: 6692996 [TBL] [Abstract][Full Text] [Related]
10. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Gabbay KH; Merola LO; Field RA Science; 1966 Jan; 151(3707):209-10. PubMed ID: 5907911 [TBL] [Abstract][Full Text] [Related]
11. [Review on the balance of energy substances with special reference to the metabolism of glucose, fructose, sorbitol and xylitol and their therapeutic utilization]. Froesch ER Int Z Vitam Ernahrungsforsch Beih; 1972; 12():73-86. PubMed ID: 4199454 [No Abstract] [Full Text] [Related]
12. Nonenzymatic browning of proteins and the sorbitol pathway. Suarez G Prog Clin Biol Res; 1989; 304():141-62. PubMed ID: 2675027 [TBL] [Abstract][Full Text] [Related]
13. Glucose utilization by the polyol pathway in human erythrocytes. Morrison AD; Clements RS; Travis SB; Oski F; Winegrad AI Biochem Biophys Res Commun; 1970 Jul; 40(1):199-205. PubMed ID: 5456956 [No Abstract] [Full Text] [Related]
14. The sorbitol pathway and the complications of diabetes. Gabbay KH N Engl J Med; 1973 Apr; 288(16):831-6. PubMed ID: 4266466 [No Abstract] [Full Text] [Related]
15. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. Jedziniak JA; Chylack LT; Cheng HM; Gillis MK; Kalustian AA; Tung WH Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):314-26. PubMed ID: 6782033 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]